Abiopharma

🔍 Lee Jonathan D. (Executive)

Company: Coupang, Inc. (CPNG)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 18,157 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 140,253.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 47,181 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 187,434.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest as follows, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date: (1) 4,540 units on July 1, 2026; (2) 4,539 units on October 1, 2026; (3) 4,539 units on January 1, 2027; and (4) 4,539 units on April 1, 2027.
• F2: Represents the grant of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The RSUs will vest as follows, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date: (1) 11,796 units on July 1, 2027; (2) 11,795 units on October 1, 2027; (3) 11,795 units on January 1, 2028; and (4) 11,795 units on April 1, 2028.